Biopharmaceuticals
HIV/AIDS
Regulatory
News Release - August 29, 2008
INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
Source: Tibotec Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.